Literature DB >> 2397006

Assessment of the anti-inflammatory action of calcium dobesilate. Effect on macrophages attaching to subcutaneously implanted coverslips in guinea pigs.

N B Piller1.   

Abstract

Calcium dobesilate (Doxium) has been shown to significantly reduce the attachment of activated and quiescent macrophages to subcutaneously implanted coverslips in guinea pigs. Since the implanted coverslips represent an inflammatory stimulus and macrophages have a dominant role in inflammation it suggests that calcium dobesilate may have a pronounced anti-inflammatory action. It is speculated that calcium dobesilate may do this by reducing the number of circulating monocytes, by blocking the action of macrophage activating factors or more likely by stimulating a more rapid production of host macrophage deactivating factors such as Transforming Growth Factor (TGF) beta 1 and 2.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2397006

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  Treatment of dry age-related macular degeneration with dobesilate.

Authors:  P Cuevas; L A Outeiriño; J Angulo; G Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-06-21

2.  Effect of Polycalcium, a mixture of Polycan and calcium lactate-gluconate in a 1:9 weight ratio, on rats with surgery-induced osteoarthritis.

Authors:  Jae-Suk Choi; Hyun-Soo Shin; Ki Young Kim; Sae Kwang Ku; In Soon Choi; Joo Wan Kim
Journal:  Exp Ther Med       Date:  2015-03-04       Impact factor: 2.447

3.  Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops.

Authors:  Pedro Cuevas; Luis Antonio Outeiriño; Carlos Azanza; Javier Angulo; Guillermo Giménez-Gallego
Journal:  Mil Med Res       Date:  2015-12-21

Review 4.  Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate-Free Radical Scavenger and Growth Factor Inhibition.

Authors:  Hermann Haller; Linong Ji; Klaus Stahl; Anna Bertram; Jan Menne
Journal:  Biomed Res Int       Date:  2017-09-26       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.